Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | UBE2M | P61081 | 6/20 | 0.37 |
| ▸ | DCUN1D1 | Q96GG9 | 6/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | SHH | Q15465 | 1/20 | 0.33 |
| ▸ | SMO | Q99835 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2800239 | 0.91 | LMNA (0.40) | ALDH1A1UBE2MDCUN1D1LMNAKDM4E | |
| SCHEMBL5042237 | 0.90 | ALDH1A1 (0.42) | ALDH1A1KMT2AMAPTUBE2MDCUN1D1 | |
| SCHEMBL2796346 | 0.89 | LMNA (0.40) | MAPTUBE2MDCUN1D1LMNA | |
| SCHEMBL2799030 | 0.87 | UBE2M (0.38) | ALDH1A1UBE2MDCUN1D1LMNASMN1; SMN2 | |
| SCHEMBL2800189 | 0.87 | UBE2M (0.38) | ALDH1A1UBE2MDCUN1D1LMNASHH | |
| SCHEMBL2797191 | 0.87 | UBE2M (0.38) | ALDH1A1UBE2MDCUN1D1LMNASHH | |
| SCHEMBL2799746 | 0.86 | LMNA (0.40) | UBE2MDCUN1D1LMNA | |
| SCHEMBL2798601 | 0.85 | UBE2M (0.36) | ALDH1A1MAPTUBE2MDCUN1D1LMNA | |
| SCHEMBL2800232 | 0.84 | ALDH1A1 (0.40) | ALDH1A1KMT2AMAPTUBE2MDCUN1D1 | |
| SCHEMBL2800311 | 0.84 | UBE2M (0.40) | ALDH1A1UBE2MDCUN1D1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329694-B2 | Quinoxalinones as antibacterial composition | TOYAMA CHEMICAL CO., LTD. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20100168418-A1 | NOVEL NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168418-A1 | NOVEL NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF | ROS1, NOX1, ARG1 | ALDH1A1 2925/4885KMT2A 1173/4885MAPT 4858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.